Veracyte, Inc. (VCYT) Ownership
VCYT ownership summary
as of October 18, 2026- Institutions
- 114.8% of shares outstanding
- Insiders
- 0.49% of shares outstanding
- Shares outstanding
- 80.4M
- Float
- 79.9M shares available to trade
- Short interest
- 14.96% 10.2M shares short
- Days to cover
- 7.05 short interest up 21.1% vs prior month
- Institutions 114.81%
- Insiders 0.49%
VCYT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 16.78% | 13.5M | $581.5M | +313,819 (+2.4%) | June 30, 2026 |
| 2 | FMR Inc | 9.58% | 7.7M | $332.1M | −61,103 (−0.8%) | June 30, 2026 |
| 3 | Artisan Partners Limited Partnership | 6.89% | 5.5M | $238.8M | +42,034 (+0.8%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 5.87% | 4.7M | $203.4M | +271,461 (+6.1%) | June 30, 2026 |
| 5 | State Street Corp | 5.84% | 4.7M | $202.6M | −345,462 (−6.8%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 4.47% | 3.6M | $155.0M | +61,690 (+1.7%) | June 30, 2026 |
| 7 | Dimensional Fund Advisors, Inc. | 3.52% | 2.8M | $121.9M | −54,566 (−1.9%) | June 30, 2026 |
| 8 | First Trust Advisors L.P. | 3.12% | 2.5M | $108.1M | +390,856 (+18.5%) | June 30, 2026 |
| 9 | ARK Investment Management LLC | 2.86% | 2.3M | $99.0M | −757,867 (−24.8%) | June 30, 2026 |
| 10 | Wellington Management Company LLP | 2.83% | 2.3M | $98.1M | −284,125 (−11.1%) | June 30, 2026 |
| 11 | Geode Capital Management, LLC | 2.62% | 2.1M | $90.7M | +146,904 (+7.5%) | June 30, 2026 |
| 12 | The Goldman Sachs Group Inc | 2.04% | 1.6M | $70.8M | +366,651 (+28.7%) | June 30, 2026 |
| 13 | Fuller & Thaler Asset Management Inc | 1.88% | 1.5M | $65.1M | +95,387 (+6.7%) | June 30, 2026 |
| 14 | William Blair Investment Management, LLC | 1.78% | 1.4M | $61.7M | +441,909 (+44.7%) | June 30, 2026 |
| 15 | GW&K Investment Management, LLC | 1.76% | 1.4M | $61.1M | −20,779 (−1.4%) | June 30, 2026 |
| 16 | Morgan Stanley - Brokerage Accounts | 1.48% | 1.2M | $51.4M | +393,988 (+49.4%) | June 30, 2026 |
| 17 | Bank of America Corp | 1.37% | 1.1M | $47.5M | −346,618 (−23.9%) | June 30, 2026 |
| 18 | Driehaus Capital Management LLC | 1.30% | 1.0M | $45.1M | +1.0M (0.0%) | June 30, 2026 |
| 19 | Northern Trust Corp | 1.24% | 996K | $43.0M | +66,654 (+7.2%) | June 30, 2026 |
| 20 | Charles Schwab Investment Management Inc | 1.17% | 940K | $40.5M | +16,410 (+1.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 3.7M shares and 7 cut 1.9M.
VCYT top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Small-Cap ETF | 5.95% | 4.8M | $206.4M | +1,071 (+0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.16% | 2.5M | $109.4M | −3,323 (−0.1%) | August 31, 2026 |
| 3 | State Street® SPDR® S&P® Biotech ETF | 2.92% | 2.3M | $101.2M | −44,700 (−1.9%) | September 30, 2026 |
| 4 | iShares Russell 2000 ETF | 2.60% | 2.1M | $90.2M | −24,128 (−1.1%) | September 30, 2026 |
| 5 | Vanguard Small Cap Index | 2.25% | 1.8M | $78.1M | −24,506 (−1.3%) | September 30, 2026 |
| 6 | First Trust NYSE Arca Biotech ETF | 1.98% | 1.6M | $68.5M | — | September 30, 2026 |
| 7 | ARK Innovation ETF | 1.92% | 1.5M | $66.6M | +8,077 (+0.5%) | September 30, 2026 |
| 8 | Vanguard Explorer Inv | 1.46% | 1.2M | $50.8M | −592,286 (−33.5%) | June 30, 2026 |
| 9 | ARK Genomic Revolution ETF | 1.29% | 1.0M | $44.9M | +2,544 (+0.2%) | September 30, 2026 |
| 10 | Vanguard MStar Small Cap Growth Indx Inv | 1.25% | 1.0M | $43.5M | −48,328 (−4.6%) | September 30, 2026 |
| 11 | Congress Small Cap Growth Institutional | 1.24% | 1.0M | $43.1M | — | September 30, 2026 |
| 12 | Fidelity Select Health Care | 1.24% | 1.0M | $43.1M | −200,000 (−16.7%) | August 31, 2026 |
| 13 | FullerThaler Behavioral Sm-Cp Gr R6 | 1.18% | 945K | $40.7M | +53,600 (+6.0%) | March 31, 2026 |
| 14 | Fidelity Small Cap Growth | 1.11% | 893K | $38.5M | −25,355 (−2.8%) | July 31, 2026 |
| 15 | Fidelity Small Cap Index | 1.10% | 886K | $38.2M | +7,594 (+0.9%) | July 31, 2026 |
| 16 | Strategic Advisers Fidelity US TtlStk | 0.95% | 760K | $32.8M | −20,000 (−2.6%) | August 31, 2026 |
| 17 | iShares S&P Small-Cap 600 Growth ETF | 0.93% | 745K | $32.1M | — | September 30, 2026 |
| 18 | State Street SPDR Port S&P 600 Sm CpETF | 0.91% | 731K | $31.5M | — | September 30, 2026 |
| 19 | Fidelity Stock Selector Small Cap | 0.83% | 664K | $28.6M | — | July 31, 2026 |
| 20 | L&G Artificial Intelligence ETF | 0.81% | 651K | $28.1M | −9,434 (−1.4%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VCYT insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | John Leite | Sell | $35.19 | 5,260 | $185,099 |
| 2026-03-04 | Marc Stapley | Sell | $35.97 | 45,523 | $1.6M |
| 2026-03-04 | Rebecca Chambers | Sell | $36.14 | 18,341 | $662,844 |
| 2026-03-04 | Annie Mcguire | Sell | $35.55 | 6,658 | $236,692 |
| 2026-03-03 | Gilbert Ray Cisneros, Jr. | Buy | $35.08 | — | — |
| 2025-12-16 | Annie Mcguire | Sell | $43.13 | 10,739 | $463,173 |
| 2025-12-05 | Karin Eastham | Sell | $45.45 | 20,000 | $909,000 |
| 2025-12-04 | Annie Mcguire | Sell | $47.30 | 1,422 | $67,261 |
| 2025-12-04 | John Leite | Sell | $47.51 | 1,278 | $60,718 |
| 2025-12-04 | Marc Stapley | Sell | $47.09 | 7,668 | $361,086 |
| 2025-12-04 | Rebecca Chambers | Sell | $46.84 | 13,278 | $621,942 |
| 2025-11-25 | Evan/ Fa Jones | Sell | $50.25 | 1,106 | $55,576 |
| 2025-11-25 | John Leite | Sell | $50.00 | 2,808 | $140,400 |
| 2025-11-20 | Jens Holstein | Sell | $42.36 | 10,000 | $423,600 |
| 2025-11-12 | Gilbert Ray Cisneros, Jr. | Sell | $42.30 | — | — |
| 2025-11-05 | Annie Mcguire | Sell | $40.00 | 6,466 | $258,640 |
| 2025-11-05 | Evan/ Fa Jones | Sell | $45.06 | 43,196 | $1.9M |
| 2025-11-05 | Karin Eastham | Sell | $40.02 | 9,674 | $387,153 |
| 2025-11-05 | Rebecca Chambers | Sell | $41.00 | 7,000 | $287,000 |
| 2025-10-06 | Phillip G Febbo | Sell | $36.02 | 8,349 | $300,731 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VCYT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VCYT
Institutional investors own 114.8% of Veracyte's shares and insiders 0.49%. The largest holder is BlackRock Inc with 16.78% of the shares (13.5M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 14.96% of the float, or 7.05 days of average trading volume. The share count rose 261.6% since 2014.
Related: VCYT analyst forecast, VCYT key metrics. See the VCYT stock overview for the latest quote and news.
VCYT ownership FAQ
Who owns the most Veracyte stock?
The largest shareholders of Veracyte are BlackRock Inc (16.78%), FMR Inc (9.58%), Artisan Partners Limited Partnership (6.89%), Vanguard Portfolio Management, LLC (5.87%), State Street Corp (5.84%).
What percentage of Veracyte is owned by institutions?
Institutions hold 114.8% of Veracyte's shares outstanding; insiders hold 0.49%.
Which funds own Veracyte?
The largest fund holders of Veracyte are iShares Core S&P Small-Cap ETF (5.95%), Vanguard MStar Total Stk Mkt Idx Invest (3.16%), State Street® SPDR® S&P® Biotech ETF (2.92%), iShares Russell 2000 ETF (2.60%), Vanguard Small Cap Index (2.25%).
What is Veracyte's short interest?
10.2M shares of Veracyte were sold short, 14.96% of the float; at the average daily volume it would take 7.05 days to cover.
Are insiders buying or selling Veracyte?
Of the latest 20 reported insider transactions in Veracyte (since October 6, 2025), 1 were purchases and 19 were sales.
How many shares of Veracyte are outstanding?
Veracyte has 80.4M shares outstanding, of which 79.9M are in the public float.